19-11039498-T-G
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1
The NM_001387283.1(SMARCA4):āc.4211T>Gā(p.Val1404Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000943 in 1,602,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1404M) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4211T>G | p.Val1404Gly | missense_variant | Exon 30 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000643549.1 | c.4112T>G | p.Val1371Gly | missense_variant | Exon 29 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.4171-1809T>G | intron_variant | Intron 29 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000541122.6 | c.4072-1800T>G | intron_variant | Intron 29 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.4072-1800T>G | intron_variant | Intron 28 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.4072-1800T>G | intron_variant | Intron 28 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.4072-1800T>G | intron_variant | Intron 29 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.3583-1800T>G | intron_variant | Intron 26 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.2815-1800T>G | intron_variant | Intron 22 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.2797-1800T>G | intron_variant | Intron 21 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.2656-1800T>G | intron_variant | Intron 21 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.2524-1800T>G | intron_variant | Intron 20 of 24 | ENSP00000494159.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.328-1800T>G | intron_variant | Intron 3 of 7 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000818 AC: 19AN: 232290 AF XY: 0.000110 show subpopulations
GnomAD4 exome AF: 0.0000945 AC: 137AN: 1449890Hom.: 0 Cov.: 29 AF XY: 0.0000818 AC XY: 59AN XY: 721088 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Observed with a second SMARCA4 variant on the opposite allele (in trans) in an individual with congenital heart disease (Preuss et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27760138, 24728327)
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Rhabdoid tumor predisposition syndrome 2 Benign:1
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at